Human CD22-Transgenic, Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor Microenvironments

Targeted immunotherapies have greatly changed treatment of patients with B cell malignancies. To further enhance immunotherapies, research increasingly focuses on the tumor microenvironment (TME), which differs considerably by organ site. However, immunocompetent mouse models of disease to study imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Gsottberger, Franziska, Brandl, Carolin, Wendland, Kerstin, Petkovic, Srdjan, Emmerich, Charlotte, Erber, Ramona, Geppert, Carol, Hartmann, Arndt, Mackensen, Andreas, Nitschke, Lars, Müller, Fabian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508822/
https://www.ncbi.nlm.nih.gov/pubmed/34638774
http://dx.doi.org/10.3390/ijms221910433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508822/
https://www.ncbi.nlm.nih.gov/pubmed/34638774
http://dx.doi.org/10.3390/ijms221910433

Ejemplares similares